Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
BCTX: BriaCell Therapeutics Corp. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
BCTX
The Story
BCTX
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+0.0% / yr
Operating margin
0.0%
ROIC
-136.3%
Financially safe
Stretched
Debt / equity
0.00×
Interest coverage
-1080.2×
Current ratio
7.07×
BriaCell Therapeutics Corp.
BCTX
NASDAQ Capital Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
BriaCell Therapeutics Corp.
BCTX
NASDAQ
·
USD
·
Closed
$3.44
−5.23%
$3.44
−$0.19 (5.23%)
52W Range
7th
pctl
Volume
0.31×
avg
Mkt Cap
6.48M
USD
P/E
-0.3
TTM
Div Yield
–
ann
52W Range
7th
pctl
Volume
0.31×
avg
Market Cap
6.48M
USD
P/E Ratio
-0.3
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings